AI MARKET SCANNING

BioCryst Pharmaceuticals, Inc.

📅 Next Catalyst: Nov 04, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Drug Manufacturers – Specialty & Generic
AVG HISTORICAL GAP +1.70%
MAX GAP RECORD +14.97%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $BCRX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 04, 2026 Earnings Release 2026-11-04 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 05, 2026 Earnings Release 2026-08-05 (BEFORE OPEN)
+4.66%
May 06, 2026 Earnings Release 2026-05-06 (BEFORE OPEN)
-4.43%
Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN)
+8.61%
Nov 03, 2025 Earnings Release 2025-11-03 (BEFORE OPEN)
-2.32%
Aug 04, 2025 Earnings Release 2025-08-04 (BEFORE OPEN)
+14.97%
May 06, 2025 Earnings Release 2025-05-06 (BEFORE OPEN)
-0.54%
Feb 24, 2025 Earnings Release 2025-02-24 (BEFORE OPEN)
-3.69%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.1%
Bullish Gaps (7)
Bearish Gaps (5)
Neutral / Flat (2)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $BCRX

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-28 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 163m +0.30%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated and seasonal influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗